Global Ertapenem Sodium for Injection Market Growth 2026-2032

January 2026 | 113 pages | ID: G461BB95E3ACEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Ertapenem Sodium for Injection market size is predicted to grow from US$ 913 million in 2025 to US$ 1438 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.

Ertapenem Sodium for Injection is a broad-spectrum antibiotic belonging to the carbapenem class of antibacterial drugs. It is administered by intravenous or intramuscular injection and is used to treat a variety of infections caused by sensitive bacteria. Ertapenem Sodium has a broad antibacterial spectrum and has good antibacterial activity against many Gram-positive and Gram-negative bacteria, as well as some anaerobic bacteria.

United States market for Ertapenem Sodium for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Ertapenem Sodium for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Ertapenem Sodium for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Ertapenem Sodium for Injection players cover Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Ertapenem Sodium for Injection Industry Forecast? looks at past sales and reviews total world Ertapenem Sodium for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Ertapenem Sodium for Injection sales for 2026 through 2032. With Ertapenem Sodium for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ertapenem Sodium for Injection industry.

This Insight Report provides a comprehensive analysis of the global Ertapenem Sodium for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ertapenem Sodium for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ertapenem Sodium for Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ertapenem Sodium for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ertapenem Sodium for Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem Sodium for Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 0.5g
  • 1g
Segmentation by Application:
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  • Qilu Anti Pharmaceutical Co., Ltd.
  • Hainan Herui Pharmaceutical Co., Ltd.
  • Sichuan Pharmaceutical Preparation Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • ACS DOBFAR SPA
  • EUGIA PHARMA INC
  • Unitech Biotech
  • NorthStar Rx
  • Par Pharmaceutical
  • Intelicure Lifesciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ertapenem Sodium for Injection market?
What factors are driving Ertapenem Sodium for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ertapenem Sodium for Injection market opportunities vary by end market size?
How does Ertapenem Sodium for Injection break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ertapenem Sodium for Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Ertapenem Sodium for Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Ertapenem Sodium for Injection by Country/Region, 2021, 2025 & 2032
2.2 Ertapenem Sodium for Injection Segment by Type
  2.2.1 0.5g
  2.2.2 1g
  2.2.3 Ertapenem Sodium for Injection Sales by Type
    2.2.3.1 Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Ertapenem Sodium for Injection Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Ertapenem Sodium for Injection Sale Price by Type (2021-2026)
2.3 Ertapenem Sodium for Injection Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Ertapenem Sodium for Injection Sales by Application
    2.3.4.1 Global Ertapenem Sodium for Injection Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Ertapenem Sodium for Injection Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Ertapenem Sodium for Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Ertapenem Sodium for Injection Breakdown Data by Company
  3.1.1 Global Ertapenem Sodium for Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Ertapenem Sodium for Injection Sales Market Share by Company (2021-2026)
3.2 Global Ertapenem Sodium for Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Ertapenem Sodium for Injection Revenue by Company (2021-2026)
  3.2.2 Global Ertapenem Sodium for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Ertapenem Sodium for Injection Sale Price by Company
3.4 Key Manufacturers Ertapenem Sodium for Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Ertapenem Sodium for Injection Product Location Distribution
  3.4.2 Players Ertapenem Sodium for Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ERTAPENEM SODIUM FOR INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Ertapenem Sodium for Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Ertapenem Sodium for Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Ertapenem Sodium for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ertapenem Sodium for Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Ertapenem Sodium for Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Ertapenem Sodium for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ertapenem Sodium for Injection Sales Growth
4.4 APAC Ertapenem Sodium for Injection Sales Growth
4.5 Europe Ertapenem Sodium for Injection Sales Growth
4.6 Middle East & Africa Ertapenem Sodium for Injection Sales Growth

5 AMERICAS

5.1 Americas Ertapenem Sodium for Injection Sales by Country
  5.1.1 Americas Ertapenem Sodium for Injection Sales by Country (2021-2026)
  5.1.2 Americas Ertapenem Sodium for Injection Revenue by Country (2021-2026)
5.2 Americas Ertapenem Sodium for Injection Sales by Type (2021-2026)
5.3 Americas Ertapenem Sodium for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ertapenem Sodium for Injection Sales by Region
  6.1.1 APAC Ertapenem Sodium for Injection Sales by Region (2021-2026)
  6.1.2 APAC Ertapenem Sodium for Injection Revenue by Region (2021-2026)
6.2 APAC Ertapenem Sodium for Injection Sales by Type (2021-2026)
6.3 APAC Ertapenem Sodium for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Ertapenem Sodium for Injection by Country
  7.1.1 Europe Ertapenem Sodium for Injection Sales by Country (2021-2026)
  7.1.2 Europe Ertapenem Sodium for Injection Revenue by Country (2021-2026)
7.2 Europe Ertapenem Sodium for Injection Sales by Type (2021-2026)
7.3 Europe Ertapenem Sodium for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ertapenem Sodium for Injection by Country
  8.1.1 Middle East & Africa Ertapenem Sodium for Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Ertapenem Sodium for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Ertapenem Sodium for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Ertapenem Sodium for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ertapenem Sodium for Injection
10.3 Manufacturing Process Analysis of Ertapenem Sodium for Injection
10.4 Industry Chain Structure of Ertapenem Sodium for Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Ertapenem Sodium for Injection Distributors
11.3 Ertapenem Sodium for Injection Customer

12 WORLD FORECAST REVIEW FOR ERTAPENEM SODIUM FOR INJECTION BY GEOGRAPHIC REGION

12.1 Global Ertapenem Sodium for Injection Market Size Forecast by Region
  12.1.1 Global Ertapenem Sodium for Injection Forecast by Region (2027-2032)
  12.1.2 Global Ertapenem Sodium for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ertapenem Sodium for Injection Forecast by Type (2027-2032)
12.7 Global Ertapenem Sodium for Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  13.1.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information
  13.1.2 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.1.3 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Main Business Overview
  13.1.5 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Latest Developments
13.2 Qilu Anti Pharmaceutical Co., Ltd.
  13.2.1 Qilu Anti Pharmaceutical Co., Ltd. Company Information
  13.2.2 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.2.3 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Qilu Anti Pharmaceutical Co., Ltd. Main Business Overview
  13.2.5 Qilu Anti Pharmaceutical Co., Ltd. Latest Developments
13.3 Hainan Herui Pharmaceutical Co., Ltd.
  13.3.1 Hainan Herui Pharmaceutical Co., Ltd. Company Information
  13.3.2 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.3.3 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Hainan Herui Pharmaceutical Co., Ltd. Main Business Overview
  13.3.5 Hainan Herui Pharmaceutical Co., Ltd. Latest Developments
13.4 Sichuan Pharmaceutical Preparation Co., Ltd.
  13.4.1 Sichuan Pharmaceutical Preparation Co., Ltd. Company Information
  13.4.2 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.4.3 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Sichuan Pharmaceutical Preparation Co., Ltd. Main Business Overview
  13.4.5 Sichuan Pharmaceutical Preparation Co., Ltd. Latest Developments
13.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  13.5.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  13.5.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.5.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Main Business Overview
  13.5.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Latest Developments
13.6 ACS DOBFAR SPA
  13.6.1 ACS DOBFAR SPA Company Information
  13.6.2 ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.6.3 ACS DOBFAR SPA Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 ACS DOBFAR SPA Main Business Overview
  13.6.5 ACS DOBFAR SPA Latest Developments
13.7 EUGIA PHARMA INC
  13.7.1 EUGIA PHARMA INC Company Information
  13.7.2 EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.7.3 EUGIA PHARMA INC Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 EUGIA PHARMA INC Main Business Overview
  13.7.5 EUGIA PHARMA INC Latest Developments
13.8 Unitech Biotech
  13.8.1 Unitech Biotech Company Information
  13.8.2 Unitech Biotech Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.8.3 Unitech Biotech Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Unitech Biotech Main Business Overview
  13.8.5 Unitech Biotech Latest Developments
13.9 NorthStar Rx
  13.9.1 NorthStar Rx Company Information
  13.9.2 NorthStar Rx Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.9.3 NorthStar Rx Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 NorthStar Rx Main Business Overview
  13.9.5 NorthStar Rx Latest Developments
13.10 Par Pharmaceutical
  13.10.1 Par Pharmaceutical Company Information
  13.10.2 Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.10.3 Par Pharmaceutical Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Par Pharmaceutical Main Business Overview
  13.10.5 Par Pharmaceutical Latest Developments
13.11 Intelicure Lifesciences
  13.11.1 Intelicure Lifesciences Company Information
  13.11.2 Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolios and Specifications
  13.11.3 Intelicure Lifesciences Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Intelicure Lifesciences Main Business Overview
  13.11.5 Intelicure Lifesciences Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Ertapenem Sodium for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ertapenem Sodium for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.5g
Table 4. Major Players of 1g
Table 5. Global Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026)
Table 7. Global Ertapenem Sodium for Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Ertapenem Sodium for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Ertapenem Sodium for Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Ertapenem Sodium for Injection Sale Market Share by Application (2021-2026)
Table 12. Global Ertapenem Sodium for Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Ertapenem Sodium for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Ertapenem Sodium for Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Ertapenem Sodium for Injection Sales Market Share by Company (2021-2026)
Table 17. Global Ertapenem Sodium for Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Ertapenem Sodium for Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Ertapenem Sodium for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Ertapenem Sodium for Injection Producing Area Distribution and Sales Area
Table 21. Players Ertapenem Sodium for Injection Products Offered
Table 22. Ertapenem Sodium for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Ertapenem Sodium for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Ertapenem Sodium for Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Ertapenem Sodium for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Ertapenem Sodium for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Ertapenem Sodium for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Ertapenem Sodium for Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Ertapenem Sodium for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Ertapenem Sodium for Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Ertapenem Sodium for Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Ertapenem Sodium for Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Ertapenem Sodium for Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Ertapenem Sodium for Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Ertapenem Sodium for Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Ertapenem Sodium for Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Ertapenem Sodium for Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Ertapenem Sodium for Injection
Table 52. Key Market Challenges & Risks of Ertapenem Sodium for Injection
Table 53. Key Industry Trends of Ertapenem Sodium for Injection
Table 54. Ertapenem Sodium for Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Ertapenem Sodium for Injection Distributors List
Table 57. Ertapenem Sodium for Injection Customer List
Table 58. Global Ertapenem Sodium for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Ertapenem Sodium for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Ertapenem Sodium for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Ertapenem Sodium for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Ertapenem Sodium for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Ertapenem Sodium for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Ertapenem Sodium for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Ertapenem Sodium for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Ertapenem Sodium for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Ertapenem Sodium for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Ertapenem Sodium for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Ertapenem Sodium for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Ertapenem Sodium for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Ertapenem Sodium for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 74. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Main Business
Table 76. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Latest Developments
Table 77. Qilu Anti Pharmaceutical Co., Ltd. Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 79. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Qilu Anti Pharmaceutical Co., Ltd. Main Business
Table 81. Qilu Anti Pharmaceutical Co., Ltd. Latest Developments
Table 82. Hainan Herui Pharmaceutical Co., Ltd. Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 84. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hainan Herui Pharmaceutical Co., Ltd. Main Business
Table 86. Hainan Herui Pharmaceutical Co., Ltd. Latest Developments
Table 87. Sichuan Pharmaceutical Preparation Co., Ltd. Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 89. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sichuan Pharmaceutical Preparation Co., Ltd. Main Business
Table 91. Sichuan Pharmaceutical Preparation Co., Ltd. Latest Developments
Table 92. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 94. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Main Business
Table 96. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Latest Developments
Table 97. ACS DOBFAR SPA Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 99. ACS DOBFAR SPA Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. ACS DOBFAR SPA Main Business
Table 101. ACS DOBFAR SPA Latest Developments
Table 102. EUGIA PHARMA INC Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 104. EUGIA PHARMA INC Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. EUGIA PHARMA INC Main Business
Table 106. EUGIA PHARMA INC Latest Developments
Table 107. Unitech Biotech Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Unitech Biotech Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 109. Unitech Biotech Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Unitech Biotech Main Business
Table 111. Unitech Biotech Latest Developments
Table 112. NorthStar Rx Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. NorthStar Rx Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 114. NorthStar Rx Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. NorthStar Rx Main Business
Table 116. NorthStar Rx Latest Developments
Table 117. Par Pharmaceutical Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 119. Par Pharmaceutical Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Par Pharmaceutical Main Business
Table 121. Par Pharmaceutical Latest Developments
Table 122. Intelicure Lifesciences Basic Information, Ertapenem Sodium for Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolios and Specifications
Table 124. Intelicure Lifesciences Ertapenem Sodium for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Intelicure Lifesciences Main Business
Table 126. Intelicure Lifesciences Latest Developments

LIST OF FIGURES

Figure 1. Picture of Ertapenem Sodium for Injection
Figure 2. Ertapenem Sodium for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ertapenem Sodium for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ertapenem Sodium for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ertapenem Sodium for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ertapenem Sodium for Injection Sales Market Share by Country/Region (2025)
Figure 10. Ertapenem Sodium for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.5g
Figure 12. Product Picture of 1g
Figure 13. Global Ertapenem Sodium for Injection Sales Market Share by Type in 2026
Figure 14. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2026)
Figure 15. Ertapenem Sodium for Injection Consumed in Hospital
Figure 16. Global Ertapenem Sodium for Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Ertapenem Sodium for Injection Consumed in Clinic
Figure 18. Global Ertapenem Sodium for Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. Ertapenem Sodium for Injection Consumed in Other
Figure 20. Global Ertapenem Sodium for Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Ertapenem Sodium for Injection Sale Market Share by Application (2025)
Figure 22. Global Ertapenem Sodium for Injection Revenue Market Share by Application in 2026
Figure 23. Ertapenem Sodium for Injection Sales by Company in 2026 (K Units)
Figure 24. Global Ertapenem Sodium for Injection Sales Market Share by Company in 2026
Figure 25. Ertapenem Sodium for Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Ertapenem Sodium for Injection Revenue Market Share by Company in 2026
Figure 27. Global Ertapenem Sodium for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Ertapenem Sodium for Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Ertapenem Sodium for Injection Sales 2021-2026 (K Units)
Figure 30. Americas Ertapenem Sodium for Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Ertapenem Sodium for Injection Sales 2021-2026 (K Units)
Figure 32. APAC Ertapenem Sodium for Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Ertapenem Sodium for Injection Sales 2021-2026 (K Units)
Figure 34. Europe Ertapenem Sodium for Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Ertapenem Sodium for Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Ertapenem Sodium for Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Ertapenem Sodium for Injection Sales Market Share by Country in 2026
Figure 38. Americas Ertapenem Sodium for Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Ertapenem Sodium for Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Ertapenem Sodium for Injection Sales Market Share by Region in 2026
Figure 46. APAC Ertapenem Sodium for Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Ertapenem Sodium for Injection Sales Market Share by Application (2021-2026)
Figure 49. China Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Ertapenem Sodium for Injection Sales Market Share by Country in 2026
Figure 57. Europe Ertapenem Sodium for Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Ertapenem Sodium for Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Ertapenem Sodium for Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Ertapenem Sodium for Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Ertapenem Sodium for Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Ertapenem Sodium for Injection in 2026
Figure 74. Manufacturing Process Analysis of Ertapenem Sodium for Injection
Figure 75. Industry Chain Structure of Ertapenem Sodium for Injection
Figure 76. Channels of Distribution
Figure 77. Global Ertapenem Sodium for Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Ertapenem Sodium for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Ertapenem Sodium for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Ertapenem Sodium for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Ertapenem Sodium for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Ertapenem Sodium for Injection Revenue Market Share Forecast by Application (2027-2032)